BALLATORE, ZELMIRA
 Distribuzione geografica
Continente #
NA - Nord America 663
EU - Europa 318
AS - Asia 94
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.103
Nazione #
US - Stati Uniti d'America 663
IT - Italia 86
UA - Ucraina 55
SE - Svezia 53
IE - Irlanda 42
CN - Cina 29
DE - Germania 27
TR - Turchia 27
DK - Danimarca 21
CI - Costa d'Avorio 20
SG - Singapore 19
FI - Finlandia 15
GB - Regno Unito 11
KR - Corea 11
IN - India 7
MA - Marocco 6
BE - Belgio 4
AT - Austria 2
EU - Europa 1
FR - Francia 1
JP - Giappone 1
PE - Perù 1
PL - Polonia 1
Totale 1.103
Città #
Chandler 116
Jacksonville 58
Ashburn 57
Dublin 42
Boardman 41
New York 40
Fairfield 36
Wilmington 29
Woodbridge 26
Seattle 24
Centro 22
Abidjan 20
Houston 19
Ancona 18
Des Moines 18
Ann Arbor 16
Cambridge 16
Lawrence 14
Princeton 14
San Mateo 12
Turin 11
San Diego 8
Pune 7
Singapore 6
Guangzhou 5
Washington 5
Beijing 4
Brussels 4
Helsinki 4
Los Angeles 4
Porto 4
Cantu 3
Chiaravalle 3
Dallas 3
London 3
Prescot 3
Wuxi 3
Kilburn 2
Marche 2
Segrate 2
Tolentino 2
Vienna 2
Arequipa 1
Bari 1
Brandenburg 1
Dalian 1
Falconara Marittima 1
Fayetteville 1
Jiaxing 1
Montegiorgio 1
Norwalk 1
Osimo 1
Prudnik 1
Sano 1
Shanghai 1
Shaoxing 1
Suzhou 1
Wuhan 1
Zibo 1
Totale 745
Nome #
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 114
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 105
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 102
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 85
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 81
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 80
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 75
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 74
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 72
Patient and caregiver needs in oncology. An Italian survey 70
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 69
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 69
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 56
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 49
Cancer patient perspective in the arena of COVID-19 pandemic 36
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 12
Totale 1.149
Categoria #
all - tutte 5.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 11 2 11 0 12 1 12 2 3 20
2020/2021210 12 22 24 1 25 16 18 16 16 31 20 9
2021/2022108 9 15 2 4 0 9 7 5 7 17 10 23
2022/2023320 22 42 15 26 24 54 0 6 74 2 45 10
2023/2024193 25 6 8 21 27 65 3 4 2 6 1 25
2024/202577 51 26 0 0 0 0 0 0 0 0 0 0
Totale 1.149